China Rheumatoid Arthritis Prescription Drug Sales Data 2006-2010Draco Healthcare Consulting LLC
November 1, 2011
More Rheumatology/Arthritis reports by Draco Healthcare Consulting LLC
China Rheumatoid Arthritis Prescription Drug Sales Data 2006-2011 by Draco Healthcare Consulting LLCSee all reports like this >>
The series of China Prescription Drug (CPD) sales reports have systemically analyzed Chinese prescription drug market, according to different therapeutic areas. All market estimates of ...
More China Rheumatology/Arthritis reports
MediPoint: Total Wrist Reconstruction - APAC Analysis and Market Forecasts by GlobalData
MediPoint: Total Wrist Reconstruction - APAC Analysis and Market ForecastsSummaryInjuries to any of the bones, ligaments, tendons or nerves in the wrist joint can cause ...
Rheumatoid Arthritis in Brazil, Russia, and China – How Are Payers and Prescribers Promoting or Limiting Growth in the Biologics Markets by Decision Resources
This report is based on a survey of 150 prescribers (rheumatologists) and interviews with 12 payers. Interviewed payers have influence at a national ...
PharmaPoint: Rheumatoid Arthritis - China Drug Forecast and Market Analysis Event-Driven Update by GlobalData
PharmaPoint: Rheumatoid Arthritis - China Drug Forecast and Market Analysis Event-Driven UpdateSummaryGlobalData has released its new Country report, “PharmaPoint: Rheumatoid Arthritis - China Drug Forecast ...
Epidemiology: Rheumatoid Arthritis in China – Rapid urbanization presents favorable market potential by DatamonitorSee all reports like this >>
IntroductionDatamonitor expects a substantial increase in prevalent rheumatoid arthritis in China over the next decade. In 2011, there were approximately 3.966 million total prevalent cases ...
More China reports
Eyewear in Hong Kong, China by Euromonitor International
Chinese mainland tourists with a preference for international spectacle brands are the key driver for high volume and value growth. Minimum wage ordinance passed in ...
D&B Country RiskLine Report: China by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
D&B Country Report: China by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
Wine - BRIC (Brazil, Russia, India, China) Industry Guide by MarketLineSee all reports like this >>
Datamonitor's Wine - BRIC (Brazil, Russia, India, China) Industry Guide is an essential resource for top-level data and analysis covering the BRIC (Brazil, Russia, India, ...
We can help you find what you need. Call us or write us:
Need help in your search?
- Rheumatoid Arthritis – Pipeline Review, H1 2013
- Rheumatoid Arthritis Partnering 2007-2013
- Rheumatology Therapeutics Market to 2018 - Increasing Uptake of Benlysta, Uloric, Krystexxa, and the Launch of Oral Tofacitinib to Spur Growth
- Rheumatoid Arthritis in Brazil, Russia, and China – How Are Payers and Prescribers Promoting or Limiting Growth in the Biologics Markets
- LaunchTrends®: Abatacept SC (Orencia SC) (Wave 4) 2012